The Valley Desk

NCT00398567 · Interventional trial

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Overall registry status Completed

Phase 1 · Phase 2

Conditions Advanced Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov